Mucosal bacterial immunotherapy with MV130 highly reduces the need of tonsillectomy in adults with recurrent tonsillitis

Recurrent tonsillitis in adults is a common ENT disease. The current standard treatment is tonsillectomy. However, continuous prophylaxis with antibiotics has been prescribed in order to avoid tonsillectomy. The objective was to evaluate if the bacterial immunotherapy (Bactek MV130) together with th...

Descripción completa

Detalles Bibliográficos
Autores principales: García González, Luis-Amando, Arrutia Díez, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773391/
https://www.ncbi.nlm.nih.gov/pubmed/30779677
http://dx.doi.org/10.1080/21645515.2019.1581537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773391/
https://www.ncbi.nlm.nih.gov/pubmed/30779677
http://dx.doi.org/10.1080/21645515.2019.1581537

Ejemplares similares